Concepts (155)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Chemokine CCL8 | 2 | 2014 | 18 | 0.520 |
Why?
|
| Th2 Cells | 4 | 2016 | 1048 | 0.520 |
Why?
|
| Chemokines, CC | 2 | 2022 | 291 | 0.470 |
Why?
|
| Receptors, CCR8 | 1 | 2013 | 27 | 0.470 |
Why?
|
| Immunity, Innate | 1 | 2023 | 2950 | 0.400 |
Why?
|
| Chemokine CCL1 | 1 | 2011 | 18 | 0.400 |
Why?
|
| Receptors, Leukotriene B4 | 3 | 2005 | 94 | 0.380 |
Why?
|
| Cytokines | 2 | 2023 | 7296 | 0.340 |
Why?
|
| Hypersensitivity | 2 | 2016 | 1086 | 0.300 |
Why?
|
| Epithelium | 1 | 2012 | 1684 | 0.300 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 4 | 2003 | 805 | 0.240 |
Why?
|
| Receptors, Purinergic P2 | 1 | 2005 | 151 | 0.240 |
Why?
|
| Dermatitis, Atopic | 1 | 2011 | 644 | 0.240 |
Why?
|
| HLA-DR Antigens | 1 | 2005 | 643 | 0.230 |
Why?
|
| Chemokines | 2 | 2022 | 948 | 0.230 |
Why?
|
| Epstein-Barr Virus Infections | 2 | 2005 | 566 | 0.210 |
Why?
|
| T-Lymphocytes | 3 | 2014 | 10140 | 0.210 |
Why?
|
| Interleukin-13 | 1 | 2023 | 388 | 0.200 |
Why?
|
| Cell Movement | 3 | 2023 | 5220 | 0.170 |
Why?
|
| Chemotaxis | 2 | 2013 | 602 | 0.170 |
Why?
|
| Skin | 2 | 2022 | 4324 | 0.170 |
Why?
|
| Asthma | 4 | 2016 | 5949 | 0.150 |
Why?
|
| Allergens | 2 | 2016 | 1308 | 0.150 |
Why?
|
| T-Lymphocytes, Cytotoxic | 2 | 2001 | 1822 | 0.150 |
Why?
|
| Skin Transplantation | 1 | 2022 | 1073 | 0.140 |
Why?
|
| Lymphocytes | 1 | 2023 | 2615 | 0.130 |
Why?
|
| Leukotriene B4 | 2 | 2005 | 293 | 0.110 |
Why?
|
| Listeriosis | 1 | 2014 | 149 | 0.110 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 1 | 2013 | 377 | 0.100 |
Why?
|
| Listeria monocytogenes | 1 | 2014 | 249 | 0.100 |
Why?
|
| Mice | 8 | 2023 | 80995 | 0.100 |
Why?
|
| Receptors, Lymphocyte Homing | 1 | 2011 | 143 | 0.090 |
Why?
|
| Adoptive Transfer | 2 | 2011 | 845 | 0.090 |
Why?
|
| Interleukin-5 | 1 | 2011 | 273 | 0.090 |
Why?
|
| Inflammation | 4 | 2016 | 10531 | 0.090 |
Why?
|
| Eosinophils | 1 | 2013 | 954 | 0.080 |
Why?
|
| HIV-1 | 3 | 2001 | 6930 | 0.080 |
Why?
|
| Ligands | 2 | 2013 | 3301 | 0.080 |
Why?
|
| Lung | 2 | 2023 | 9778 | 0.070 |
Why?
|
| Cloning, Molecular | 2 | 2011 | 4319 | 0.070 |
Why?
|
| Calcium Signaling | 1 | 2011 | 721 | 0.070 |
Why?
|
| Bronchoalveolar Lavage Fluid | 2 | 2005 | 764 | 0.070 |
Why?
|
| Animals | 9 | 2023 | 168358 | 0.070 |
Why?
|
| Phylogeny | 1 | 2013 | 2788 | 0.070 |
Why?
|
| Receptors, Interleukin-8A | 1 | 2005 | 44 | 0.070 |
Why?
|
| Toxoplasmosis | 1 | 2006 | 92 | 0.070 |
Why?
|
| Receptors, CCR6 | 1 | 2005 | 80 | 0.070 |
Why?
|
| Immunologic Memory | 1 | 2012 | 1348 | 0.060 |
Why?
|
| Transfection | 1 | 2013 | 5884 | 0.060 |
Why?
|
| Food Hypersensitivity | 1 | 2012 | 613 | 0.060 |
Why?
|
| Receptors, CCR2 | 1 | 2005 | 212 | 0.060 |
Why?
|
| Interferon-gamma | 4 | 2006 | 3193 | 0.060 |
Why?
|
| Mice, Knockout | 5 | 2014 | 14555 | 0.060 |
Why?
|
| Bronchiolitis Obliterans | 1 | 2005 | 193 | 0.060 |
Why?
|
| Receptors, CCR5 | 1 | 2006 | 497 | 0.060 |
Why?
|
| Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 1 | 2003 | 97 | 0.060 |
Why?
|
| Genes, T-Cell Receptor beta | 1 | 2003 | 72 | 0.060 |
Why?
|
| Pseudogenes | 1 | 2003 | 113 | 0.060 |
Why?
|
| Herpesvirus 4, Human | 2 | 2005 | 1038 | 0.060 |
Why?
|
| Pan troglodytes | 1 | 2003 | 229 | 0.050 |
Why?
|
| Cells, Cultured | 2 | 2011 | 19223 | 0.050 |
Why?
|
| HIV Infections | 4 | 2002 | 16763 | 0.050 |
Why?
|
| Receptors, Chemokine | 1 | 2005 | 669 | 0.050 |
Why?
|
| Cell Line | 3 | 2013 | 15982 | 0.050 |
Why?
|
| Gene Products, vpr | 1 | 2001 | 36 | 0.050 |
Why?
|
| Interleukin-4 | 1 | 2005 | 1139 | 0.050 |
Why?
|
| Orthomyxoviridae | 1 | 2002 | 158 | 0.050 |
Why?
|
| Protein Binding | 1 | 2013 | 9381 | 0.050 |
Why?
|
| T-Lymphocyte Subsets | 3 | 2003 | 1834 | 0.050 |
Why?
|
| Gene Expression | 1 | 2013 | 7789 | 0.050 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2003 | 4377 | 0.050 |
Why?
|
| Calcium | 1 | 2013 | 5739 | 0.050 |
Why?
|
| Macrophages | 1 | 2014 | 5631 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 4 | 2011 | 21859 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2003 | 2833 | 0.040 |
Why?
|
| Clone Cells | 1 | 2001 | 1690 | 0.040 |
Why?
|
| Lymphocyte Activation | 2 | 2005 | 5521 | 0.040 |
Why?
|
| Killer Cells, Natural | 1 | 2006 | 2133 | 0.040 |
Why?
|
| Lung Transplantation | 1 | 2005 | 1153 | 0.040 |
Why?
|
| Zalcitabine | 1 | 1996 | 42 | 0.040 |
Why?
|
| Disease Models, Animal | 3 | 2011 | 18002 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2014 | 12064 | 0.030 |
Why?
|
| RNA-Directed DNA Polymerase | 1 | 1996 | 248 | 0.030 |
Why?
|
| Viral Proteins | 1 | 2002 | 1900 | 0.030 |
Why?
|
| Mucus | 1 | 2016 | 321 | 0.030 |
Why?
|
| Acute Disease | 1 | 2005 | 7127 | 0.030 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2005 | 4424 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2014 | 12134 | 0.030 |
Why?
|
| Humans | 13 | 2022 | 739219 | 0.030 |
Why?
|
| Reverse Transcriptase Inhibitors | 1 | 1996 | 624 | 0.030 |
Why?
|
| Muscle, Smooth | 1 | 2016 | 929 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2014 | 339 | 0.030 |
Why?
|
| Graft Rejection | 1 | 2005 | 4379 | 0.030 |
Why?
|
| Case-Control Studies | 2 | 2005 | 21691 | 0.020 |
Why?
|
| Chronic Disease | 2 | 2002 | 9132 | 0.020 |
Why?
|
| Proteomics | 1 | 2002 | 3584 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2022 | 4143 | 0.020 |
Why?
|
| Molecular Sequence Data | 4 | 2003 | 18124 | 0.020 |
Why?
|
| Hybridization, Genetic | 1 | 2006 | 112 | 0.020 |
Why?
|
| Base Sequence | 3 | 2005 | 12807 | 0.020 |
Why?
|
| Amino Acid Sequence | 3 | 2003 | 13815 | 0.020 |
Why?
|
| Survival | 1 | 2006 | 162 | 0.020 |
Why?
|
| DNA, Protozoan | 1 | 2006 | 237 | 0.020 |
Why?
|
| Toxoplasma | 1 | 2006 | 150 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2001 | 13880 | 0.020 |
Why?
|
| Phenotype | 2 | 2016 | 16300 | 0.020 |
Why?
|
| Disease Progression | 1 | 2001 | 13237 | 0.020 |
Why?
|
| Interleukin-12 | 1 | 2006 | 578 | 0.010 |
Why?
|
| Hepatitis, Viral, Animal | 1 | 2003 | 12 | 0.010 |
Why?
|
| Time Factors | 2 | 2006 | 40040 | 0.010 |
Why?
|
| Antiviral Agents | 1 | 1996 | 2971 | 0.010 |
Why?
|
| Ovalbumin | 1 | 2005 | 719 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 2006 | 1837 | 0.010 |
Why?
|
| Flow Cytometry | 2 | 2003 | 5959 | 0.010 |
Why?
|
| Complementarity Determining Regions | 1 | 2002 | 150 | 0.010 |
Why?
|
| vpr Gene Products, Human Immunodeficiency Virus | 1 | 2001 | 39 | 0.010 |
Why?
|
| Gene Products, vif | 1 | 2001 | 33 | 0.010 |
Why?
|
| Immunodominant Epitopes | 1 | 2002 | 267 | 0.010 |
Why?
|
| vif Gene Products, Human Immunodeficiency Virus | 1 | 2001 | 53 | 0.010 |
Why?
|
| Human Immunodeficiency Virus Proteins | 1 | 2001 | 65 | 0.010 |
Why?
|
| Viral Regulatory and Accessory Proteins | 1 | 2001 | 157 | 0.010 |
Why?
|
| Neutrophils | 1 | 2014 | 3698 | 0.010 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2003 | 675 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2014 | 7716 | 0.010 |
Why?
|
| Trachea | 1 | 2005 | 1074 | 0.010 |
Why?
|
| Disease Susceptibility | 1 | 2006 | 1778 | 0.010 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2003 | 876 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 2003 | 2257 | 0.010 |
Why?
|
| Immunoglobulin E | 1 | 2003 | 1461 | 0.010 |
Why?
|
| Collagen | 1 | 2005 | 2669 | 0.010 |
Why?
|
| Saquinavir | 1 | 1996 | 29 | 0.010 |
Why?
|
| Deoxyribonucleotides | 1 | 1996 | 42 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2005 | 6391 | 0.010 |
Why?
|
| Base Composition | 1 | 1996 | 294 | 0.010 |
Why?
|
| Hepacivirus | 1 | 2003 | 1371 | 0.010 |
Why?
|
| HIV Reverse Transcriptase | 1 | 1996 | 215 | 0.010 |
Why?
|
| Epitopes | 1 | 2001 | 2558 | 0.010 |
Why?
|
| Lamivudine | 1 | 1996 | 342 | 0.010 |
Why?
|
| Isoquinolines | 1 | 1996 | 368 | 0.010 |
Why?
|
| Neutralization Tests | 1 | 1996 | 757 | 0.010 |
Why?
|
| HIV Protease Inhibitors | 1 | 1996 | 435 | 0.010 |
Why?
|
| Drug Resistance, Microbial | 1 | 1996 | 860 | 0.010 |
Why?
|
| Hepatitis C | 1 | 2003 | 1580 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2005 | 9738 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2003 | 4521 | 0.010 |
Why?
|
| Quinolines | 1 | 1996 | 720 | 0.010 |
Why?
|
| HIV Antibodies | 1 | 1996 | 1309 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2001 | 5073 | 0.010 |
Why?
|
| Virus Replication | 1 | 1996 | 2529 | 0.000 |
Why?
|
| RNA, Messenger | 1 | 2002 | 13006 | 0.000 |
Why?
|
| Reproducibility of Results | 1 | 2002 | 19787 | 0.000 |
Why?
|
| Adult | 1 | 2016 | 213375 | 0.000 |
Why?
|
| Mutation | 1 | 1996 | 29659 | 0.000 |
Why?
|
| Male | 1 | 2003 | 348967 | 0.000 |
Why?
|
| Female | 1 | 2003 | 378808 | 0.000 |
Why?
|
Concepts
(155)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(32)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_